Quadrivalent influenza vaccination is recommended annually for adults and children aged six months to 64 years
High-dose or adjuvanted trivalent vaccines are recommended annually for people 65 years and over
If started early enough, neuraminidase inhibitors reduce symptom duration by approximately one day. Treatment should be considered in patients with severe disease requiring hospitalisation or who are at risk of complications
Chemoprophylaxis is not a substitute for vaccination but can be considered in high-risk individuals with an inadequate or ineffective vaccination status
Keywords: antivirals; chemoprophylaxis; influenza; vaccines.